Close Menu

NEW YORK – Becton Dickinson disclosed this week that it is offering a total of $1.5 billion in notes to repay some debt and to fund a partial redemption of other notes.

In a document filed with the US Securities and Exchange Commission on Monday, the Franklin Lakes, New Jersey-based firm said it is offering $750 million aggregate principal amount of 2.823 percent notes due in 2030 and $750 million aggregate principal amount of 3.794 percent notes due in 2050. The notes will be payable in cash semiannually in arrears on May 20 and Nov. 20 of each year starting this November.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.